These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10776648)

  • 41. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
    Miyagawa T
    Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bronchial asthma showing reduction in FEV1 after inhalation of Qvar.
    Nobata K; Fujimura M; Myou S; Ishiura Y; Mizuguchi M; Nishi K; Nakao S
    J Asthma; 2006 Aug; 43(6):427-8. PubMed ID: 16952859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of protease inhibitor on the progress of bronchial asthma.
    Szymaniec J; Potocka Z; Rogala E; Socha B
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):871-3. PubMed ID: 95090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.
    Fink J; Dhand R
    Respir Care; 2000 May; 45(5):497-512. PubMed ID: 10813227
    [No Abstract]   [Full Text] [Related]  

  • 45. Changes in transfer factor of the lung in response to bronchodilatation.
    Akesson U; Dahlström JA; Wollmer P
    Clin Physiol; 2000 Jan; 20(1):14-8. PubMed ID: 10651787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interpretation of increases in the transfer coefficient for carbon monoxide (TLCO/VA or KCO).
    Lipscomb DJ; Patel K; Hughes JM
    Thorax; 1978 Dec; 33(6):728-33. PubMed ID: 746497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitric oxide synthase in bronchial epithelium and nitric oxide metabolites in the lungs of rats with bronchial asthma after fenoterol inhalation.
    Eliseeva EV; Kulakova NV; Nevzorova VA
    Bull Exp Biol Med; 2000 Aug; 130(8):763-5. PubMed ID: 11177237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experience with the inhalation of Berotec powder in the treatment of asthma in children.
    Bach-Mortensen N
    Eur J Respir Dis Suppl; 1983; 130():25-7. PubMed ID: 6581058
    [No Abstract]   [Full Text] [Related]  

  • 49. Beta-agonists and asthma treatment.
    Mathieson A
    Nurs Stand; 1991 Oct 2-8; 6(2):30-2. PubMed ID: 1680370
    [No Abstract]   [Full Text] [Related]  

  • 50. Lung transfer components in hyperthyroidism.
    Mahajan KK; Gupta D; Malhotra KC; Mishra N
    J Assoc Physicians India; 1991 Aug; 39(8):618-20. PubMed ID: 1814878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Disorders of pulmonary gas diffusion in liver cirrhosis].
    Tulafić C; Perisic M; Rebić P
    Srp Arh Celok Lek; 2002; 130(3-4):68-72. PubMed ID: 12154517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The single breath transfer factor (Tl,co) and the transfer coefficient (Kco): a window onto the pulmonary microcirculation.
    Hughes JM
    Clin Physiol Funct Imaging; 2003 Mar; 23(2):63-71. PubMed ID: 12641599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The behavior of the diffusion capacity, DCO during various lengths of time of holding the breath in healthy subjects and in patients with chronic bronchial asthma and with pulmonary emphysema].
    Magnussen H; Holle JP; Hartmann V
    Verh Dtsch Ges Inn Med; 1978; (84):387-8. PubMed ID: 742063
    [No Abstract]   [Full Text] [Related]  

  • 54. [New aspects in the pathophysiology of bronchial asthma (author's transl)].
    Jäger L
    Z Erkr Atmungsorgane; 1976 Mar; 144(3):240-5. PubMed ID: 960766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Routine use of beta-adrenergic agonists in asthma.
    Wanner A; Sears MR
    Am J Respir Crit Care Med; 1995 Aug; 152(2):823. PubMed ID: 7633750
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of a selective beta-2-stimulating sympathicomimetic on lung function, intrapulmonary gas exchange and physical working capacity in bronchial asthma].
    Koch K; Ingestad R
    Nord Med; 1970 Nov; 84(47):1504-5. PubMed ID: 4395496
    [No Abstract]   [Full Text] [Related]  

  • 57. [Letter: What does Berotec mean for asthma patients?].
    Dahl R
    Ugeskr Laeger; 1976 Mar; 138(12):759. PubMed ID: 1258199
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical study of a new bronchodilator molecule in pediatrics (Th 1165, Fenoterol-Berotec)].
    Longo L; Patruno D; Tempesta A; Scaramuzzi O; Laudadio L
    Minerva Pediatr; 1981 Aug; 33(16):831-4. PubMed ID: 7311945
    [No Abstract]   [Full Text] [Related]  

  • 59. A simple method of correcting diffusing capacity for alveolar volume reduction in restrictive lung diseases.
    González Mangado N; Avilés Inglés MJ; Peces-Barba G; Arévalo González M; Lahoz Navarro F
    Respiration; 1987; 52(3):163-70. PubMed ID: 3438578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Interpreting carbon monoxide transfer coefficient: significance and difficulties].
    Guillot S; Beillot J; Meunier C; Dassonville J
    Rev Mal Respir; 2005 Nov; 22(5 Pt 1):759-66. PubMed ID: 16272978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.